PRODUCT FOCUS :: ASSAYS IgG antibody test
Ortho Clinical Diagnostics’ COVID-19 IgG Quantitative Test is an antibody test calibrated to the International Standard for anti-SARS-CoV-2 IgG antibodies from the World Health Organization (WHO). It is a standard tool to measure antibody response and intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2. Ortho Clinical Diagnostics
Respiratory panel The QIAstat-Dx Respiratory SARS-CoV-2 Panel, which runs on the QIAstat-Dx Analyzer, uses
real-time PCR to detect 21 respiratory pathogens in about an hour. The QIAstat-Dx Analyzer and cartridges are designed as a closed system that contains all necessary reagents, ensuring a fast and easy workflow. Qiagen
SARS-CoV-2 and flu combo test The Aptima SARS-CoV-2/Flu Assay is available for simultaneous detection and differentiation of
three respiratory viruses - SARS-CoV-2, influenza A and influenza B. Hologic’s multiplex test runs on Hologic’s fully automated Panther system, which provides initial results in approximately three hours and can process more than 1,000 tests in 24 hours. Hologic
Point-of-care test The CLIA-waived Acucy Influenza A&B Test on the Acucy System is a rapid (result in 15 minutes)
chromatographic immunoassay that provides clinicians with flexibility in the workflow, with read- now or walk-away mode, easy transfer of results to the electronic health record (EHR), and stan- dardized results for improved patient care. Sekisui Diagnostics
Miscellaneous assays HPV assay
The BD Onclarity HPV Assay with extended genotyping can individually identify and track persis- tence for high-risk HPV genotypes beyond 16 and 18, including HPV 31, which poses a similar risk for cervical pre-cancer and cancer, as compared to HPV 18. BD
Alzheimer’s disease assay
The Randox apolipoprotein E4 (ApoE4) assay saves laboratories time and money by eliminating the requirement for genetic ApoE4 testing. The direct determination of ApoE4 status from a plasma sample can be applied to determine Alzheimer’s disease in basic clinical research, as well as in personalized medicine. The test runs on the Evidence Investigator analyzer. Randox
42 JANUARY 2022
MLO-ONLINE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50
